Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

NCT01897532 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

6991

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: Linagliptin

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]